IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ADAM T CHERRY

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1770805673
CMS profile
10791667
Location
LONGVIEW, WA

General Payments · PY2021–2024

$11,583.46

  • Reported across 264 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,458.11

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Physician Assistant WA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,840.03 2
Travel and Lodging $1,337.79 2
Food and Beverage $1,280.29 47

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BioCryst US Sales Co., LLC $2,840.03 2
BioCryst Pharmaceuticals, Inc. $1,337.79 2
Acerta Pharma LLC $342.37 12
Blueprint Medicines Corporation $160.49 3
Lilly USA, LLC $132.38 3
Takeda Pharmaceuticals U.S.A., Inc. $104.36 5
CSL Behring $96.72 4
Pharming Healthcare, Inc. $79.53 4
Regeneron Healthcare Solutions, Inc. $67.83 3
TerSera Therapeutics LLC $63.72 2
Phathom Pharmaceuticals, Inc. $61.33 2
GlaxoSmithKline, LLC. $50.04 3
NOVARTIS PHARMACEUTICALS CORPORATION $49.52 3
Genentech USA, Inc. $48.28 2
PFIZER INC. $23.72 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,936.39 97
PY2022 $3,000.02 93
PY2023 $1,188.94 23
PY2024 $5,458.11 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $23.52 07/01/2024 Food and Beverage Undisputed 01/23/2026 1105845091 CMS
AstraZeneca Pharmaceuticals LP $32.71 07/16/2024 Food and Beverage Undisputed 01/23/2026 1104723879 CMS
AstraZeneca Pharmaceuticals LP $25.20 07/31/2024 Food and Beverage Undisputed 01/23/2026 1104316440 CMS
AstraZeneca Pharmaceuticals LP $17.57 08/19/2024 Food and Beverage Undisputed 01/23/2026 1104749834 CMS
AstraZeneca Pharmaceuticals LP $22.71 09/16/2024 Food and Beverage Undisputed 01/23/2026 1104304060 CMS
AstraZeneca Pharmaceuticals LP $124.99 09/17/2024 Food and Beverage Undisputed 01/23/2026 1105209634 CMS
AstraZeneca Pharmaceuticals LP $27.68 10/02/2024 Food and Beverage Undisputed 01/23/2026 1104735021 CMS
AstraZeneca Pharmaceuticals LP $15.22 10/29/2024 Food and Beverage Undisputed 01/23/2026 1105726081 CMS
AstraZeneca Pharmaceuticals LP $18.67 11/06/2024 Food and Beverage Undisputed 01/23/2026 1105823373 CMS
AstraZeneca Pharmaceuticals LP $1.11 11/25/2024 Food and Beverage Undisputed 01/23/2026 1104475130 CMS
AstraZeneca Pharmaceuticals LP $17.82 11/25/2024 Food and Beverage Undisputed 01/23/2026 1105843539 CMS
AstraZeneca Pharmaceuticals LP $15.17 12/03/2024 Food and Beverage Undisputed 01/23/2026 1105819451 CMS
BioCryst Pharmaceuticals, Inc. $1,100.96 07/29/2024 Travel and Lodging Undisputed 01/23/2026 1117476572 CMS
BioCryst Pharmaceuticals, Inc. $236.83 08/08/2024 Travel and Lodging Undisputed 01/23/2026 1117474094 CMS
BioCryst US Sales Co., LLC $188.03 08/21/2024 Consulting Fee Undisputed 01/23/2026 1117469605 CMS
BioCryst US Sales Co., LLC $2,652.00 08/21/2024 Consulting Fee Undisputed 01/23/2026 1117478250 CMS
Blueprint Medicines Corporation $23.55 10/14/2024 Food and Beverage Undisputed 01/23/2026 1147451811 CMS
Blueprint Medicines Corporation $19.16 11/26/2024 Food and Beverage Undisputed 01/23/2026 1147451837 CMS
Blueprint Medicines Corporation $117.78 12/17/2024 Food and Beverage Undisputed 01/23/2026 1147451867 CMS
CSL Behring $30.06 06/27/2024 Food and Beverage Undisputed 01/23/2026 1134596959 CMS
CSL Behring $29.74 10/01/2024 Food and Beverage Undisputed 01/23/2026 1134596979 CMS
CSL Behring $20.31 11/13/2024 Food and Beverage Undisputed 01/23/2026 1134597015 CMS
CSL Behring $16.61 12/17/2024 Food and Beverage Undisputed 01/23/2026 1134597017 CMS
Genentech USA, Inc. $25.58 05/23/2024 Food and Beverage Undisputed 01/23/2026 1133137677 CMS
Genentech USA, Inc. $22.70 12/17/2024 Food and Beverage Undisputed 01/23/2026 1133137681 CMS
GlaxoSmithKline, LLC. $14.34 07/24/2024 Food and Beverage Undisputed 01/23/2026 1116143851 CMS
GlaxoSmithKline, LLC. $19.25 10/07/2024 Food and Beverage Undisputed 01/23/2026 1116733734 CMS
GlaxoSmithKline, LLC. $16.45 10/29/2024 Food and Beverage Undisputed 01/23/2026 1116635928 CMS
Lilly USA, LLC $5.80 10/21/2024 Food and Beverage Undisputed 01/23/2026 1135480559 CMS
Lilly USA, LLC $117.78 11/19/2024 Food and Beverage Undisputed 01/23/2026 1135480557 CMS
Lilly USA, LLC $8.80 12/02/2024 Food and Beverage Undisputed 01/23/2026 1135516018 CMS
Novartis Pharmaceuticals Corporation $14.70 01/08/2024 Food and Beverage Undisputed 01/23/2026 1086756301 CMS
Novartis Pharmaceuticals Corporation $14.70 01/23/2024 Food and Beverage Undisputed 01/23/2026 1086756295 CMS
Novartis Pharmaceuticals Corporation $20.12 06/18/2024 Food and Beverage Undisputed 01/23/2026 1086756309 CMS
PFIZER INC. $23.72 03/08/2024 Food and Beverage Undisputed 01/23/2026 1131209781 CMS
Pharming Healthcare, Inc. $25.00 01/11/2024 Food and Beverage Undisputed 01/23/2026 1132174399 CMS
Pharming Healthcare, Inc. $15.00 07/23/2024 Food and Beverage Undisputed 01/23/2026 1132174407 CMS
Pharming Healthcare, Inc. $21.86 09/23/2024 Food and Beverage Undisputed 01/23/2026 1132174417 CMS
Pharming Healthcare, Inc. $17.67 10/28/2024 Food and Beverage Undisputed 01/23/2026 1132174424 CMS
Phathom Pharmaceuticals, Inc. $28.50 09/12/2024 Food and Beverage Undisputed 01/23/2026 1151155253 CMS
Phathom Pharmaceuticals, Inc. $32.83 10/16/2024 Food and Beverage Undisputed 01/23/2026 1151155255 CMS
Regeneron Healthcare Solutions, Inc. $22.04 07/18/2024 Food and Beverage Undisputed 01/23/2026 1114284037 CMS
Regeneron Healthcare Solutions, Inc. $17.70 11/05/2024 Food and Beverage Undisputed 01/23/2026 1114284039 CMS
Regeneron Healthcare Solutions, Inc. $28.09 11/18/2024 Food and Beverage Undisputed 01/23/2026 1114284041 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.20 03/21/2024 Food and Beverage Undisputed 01/23/2026 1137725146 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.96 05/28/2024 Food and Beverage Undisputed 01/23/2026 1137725148 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.82 09/17/2024 Food and Beverage Undisputed 01/23/2026 1137725150 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.48 09/25/2024 Food and Beverage Undisputed 01/23/2026 1137725152 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.90 11/19/2024 Food and Beverage Undisputed 01/23/2026 1137725154 CMS
TerSera Therapeutics LLC $37.31 01/18/2024 Food and Beverage Undisputed 01/23/2026 1144719442 CMS
TerSera Therapeutics LLC $26.41 09/20/2024 Food and Beverage Undisputed 01/23/2026 1144719444 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.